Evidence map›Paper›PMID 42135501›Full record

ArticleNature nanotechnology2026

Glycan atlassing enables functional tracing of cell state.

Dijo Moonnukandathil Joseph, Nazlican Yurekli, Sarah Fritsche, Reem Hashem, Oana-Maria Thoma, Imen Larafa, Tina Boric, Chloé Bielawski, Karim Almahayni, Kristian Franze and 2 more

Abstract read
In one paragraph

Article in Nature nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dijo Moonnukandathil Joseph *Max Planck Institute for the Science of Light, Erlangen, Germany.
Nazlican Yurekli *Max Planck Institute for the Science of Light, Erlangen, Germany.
Sarah FritscheMax Planck Institute for the Science of Light, Erlangen, Germany.ORCID http://orcid.org/0009-0005-7102-934X
Reem HashemMax Planck Institute for the Science of Light, Erlangen, Germany.
Oana-Maria ThomaFaculty of Medicine, University Hospital Erlangen, FAU Erlangen-Nuremberg, Erlangen, Germany.ORCID http://orcid.org/0000-0002-1665-9753
Imen LarafaFaculty of Medicine, University Hospital Erlangen, FAU Erlangen-Nuremberg, Erlangen, Germany.
Tina BoricMax-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.
Chloé BielawskiMax Planck Institute for the Science of Light, Erlangen, Germany.ORCID http://orcid.org/0009-0008-6574-9369
Karim AlmahayniMax Planck Institute for the Science of Light, Erlangen, Germany.ORCID http://orcid.org/0000-0001-6844-4327
Kristian FranzeMax-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.
Maximilian J WaldnerFaculty of Medicine, University Hospital Erlangen, FAU Erlangen-Nuremberg, Erlangen, Germany.ORCID http://orcid.org/0000-0002-5560-7665
Leonhard MöcklMax Planck Institute for the Science of Light, Erlangen, Germany. leonhard.moeckl@fau.de.ORCID http://orcid.org/0000-0003-1387-886X

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 460333672 and 270949263Deutsche Forschungsgemeinschaft (German Research Foundation) 529257351EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101118729Else Kröner-Fresenius-Stiftung (Else Kroner-Fresenius Foundation) 2020_EKEA.91Wilhelm Sander-Stiftung (Wilhelm Sander Foundation) 2023.025.1
6 · The paper itself

Abstract

The glycocalyx is a complex layer of glycosylated molecules that surrounds all cells in the human body. It is involved in regulating critical cellular processes, including immune response modulation, cell adhesion and host-pathogen interactions. Despite these insights, the functional relationship between the glycocalyx architecture and cellular state has remained elusive, largely due to the structural diversity of glycocalyx constituents and their nanoscale organization. Here we show that DNA-tagged lectin labelling and metabolic oligosaccharide engineering enable multiplexed super-resolution microscopy of the glycocalyx constituents, yielding an atlas of glycocalyx architecture with nanometre resolution. Quantitative analysis of the obtained nanoscale map of glycocalyx constituents facilitates the extraction of characteristic spatial relationships that accurately report on the cellular state. We demonstrate the capacity of our approach, which we term glycan atlassing, across cell and tissue types, ranging from cultured cell lines to primary immune cells, neurons and primary patient tissue. Glycan atlassing establishes a transformative strategy for investigating glycocalyx remodelling in development and disease, potentially enabling the development of glycocalyx-centred targets in diagnosis and therapy.

Indexed as

GlycocalyxPolysaccharidesAnimalsHumansLectinsLectinsPolysaccharides

Identifiers

PMID42135501
PMCPMC13186696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.